DVA - DAVITA INC.


149.94
-4.850   -3.235%

Share volume: 862,448
Last Updated: 03-05-2026
Healthcare/Services – Health: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$154.79
-4.85
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
59%
Profitability 58%
Dept financing 40%
Liquidity 71%
Performance 63%
Company vs Stock growth
vs
Performance
5 Days
-2.62%
1 Month
6.47%
3 Months
28.10%
6 Months
11.47%
1 Year
6.83%
2 Year
13.61%
Key data
Stock price
$149.94
P/E Ratio 
10.74
DAY RANGE
$148.13 - $152.84
EPS 
$10.06
52 WEEK RANGE
$101.00 - $159.42
52 WEEK CHANGE
$1.99
MARKET CAP 
8.021 B
YIELD 
N/A
SHARES OUTSTANDING 
66.800 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
0.99
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$811,842
AVERAGE 30 VOLUME 
$1,160,688
Company detail
CEO: Javier J. Rodriguez
Region: US
Website: davita.com
Employees: 70,000
IPO year: 1995
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients. The company provides acute inpatient dialysis. services in approximately 850 hospitals and related laboratory services.

Recent news